Search

Your search keyword '"Koscielny, Serge"' showing total 414 results

Search Constraints

Start Over You searched for: Author "Koscielny, Serge" Remove constraint Author: "Koscielny, Serge"
414 results on '"Koscielny, Serge"'

Search Results

3. A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer

4. Supplementary Table 3 from Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

5. Supplementary Table 2 from Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

6. Supplementary Table 1 from Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

7. Supplementary figures 1 and 2 from Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

8. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

9. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia

10. A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies

13. Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma

16. Diagnostic accuracy of in vivo early tumor imaging from probe-based confocal laser endomicroscopy versus histologic examination in head and neck squamous cell carcinoma

17. Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis

21. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S

24. Effect of formaldehyde on asthmatic response to inhaled allergen challenge

25. Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non–Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy

44. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

46. Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

50. Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma

Catalog

Books, media, physical & digital resources